• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Jim Stommen

Articles by Jim Stommen

Different takes on building to flip or building a company

May 24, 2011
By Jim Stommen
MINNEAPOLIS – Two panel discussions during the 10th annual MedTech Investing Conference fit together so well that's it's a wonder they weren't scheduled this close together on the agenda, rather than having a couple of unrelated topics take the attendees in different directions, at least for a while. (Medical Device Daily)
Read More

Funding gap is a continuing problem for start-up firms

May 23, 2011
By Jim Stommen
MINNEAPOLIS – Saying that there's a funding gap for entrepreneur-driven, potentially innovative medical technology companies isn't news. News outlets covering both med-tech and the venture capital business – this publication certainly among them – have been carrying that message for two going on three years now. (Medical Device Daily)
Read More

Is innovation going elsewhere? Well, yes, and here's why

May 20, 2011
By Jim Stommen

Mauna Kea's Cellvizio shows results in 1st registry study

May 16, 2011
By Jim Stommen

Avantis Medical's Third Eye a new look at colonoscopies

May 11, 2011
By Jim Stommen
Rick Randall has served as CEO of some of America's most innovative young medical-products companies, so when he talks about the positive vibes he's receiving from the clinical community about his latest company, Avantis Medical Systems (Sunnyvale, California), it's worth a listen. (Medical Device Daily)
Read More

CardioNexus, Panasonic team up on office-based system for heart disease

May 1, 2011
By Jim Stommen

Berwick nomination stymied by poisonous partisan politics

April 14, 2011
By Jim Stommen
 By most objective accounts, Donald Berwick is doing a pretty decent job as chief administrator of the Centers for Medicare & Medicaid Services, giving CMS a much-needed shot in the arm and kick in the . . . well, you know. Unfortunately, that appears to not be enough for him to keep the job beyond the end of the year, as mandated by law for "recess" appointments such as himself. Berwick, who knows the provider side of medicine as a pediatrician, is a health policy expert of some repute. He has been quite the thinker on broader healthcare questions, including...
Read More

Everist hits the market with its colorectal cancer assay

April 13, 2011
By Jim Stommen
Armed with the positive results of an external validation study that were unveiled during a conference in San Francisco earlier this year, Everist Genomics (Ann Arbor, Michigan) has reported the worldwide commercial availability of its OncoDefender-CRC colorectal cancer assay. (Medical Device Daily)
Read More

CorMedix sees big opportunity with drug/device combination

April 11, 2011
By Jim Stommen

CardioNexus gets a push from Panasonic, FDA nod for device

March 29, 2011
By Jim Stommen
A young Texas company that is the result of a unique partnership involving a gigantic global maker of consumer electronics has received FDA approval to sell its ultrasound-based system for the early detection of heart disease, with sales having begun immediately upon receipt of the agency's go-ahead last week. (Medical Device Daily)
Read More
Previous 1 2 … 8 9 10 11 12 13 14 15 16 … 31 32 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 8, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 8, 2025.
  • US flag, stock market chart, White House

    100 days of uncertainty

    BioWorld
    The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
  • Illustration of cancer tumor on pancreas

    PIKfyve enzyme is target to ‘starve’ pancreatic cancer cells

    BioWorld
    A metabolic vulnerability of pancreatic ductal adenocarcinoma (PDAC) could be used to address this type of cancer that often resists treatments. Scientists at the...
  • AI generated, 3D rendering of protein degradation

    AACR 2025: Induced proximity strategy, beyond degraders

    BioWorld
    Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe